Immunoregulation of Human Tumor Growth in Nude Mice

2015 ◽  
pp. 438-445
Author(s):  
A.M.C. Koros
Keyword(s):  
2011 ◽  
Vol 302 (2) ◽  
pp. 119-127 ◽  
Author(s):  
Fujia Lv ◽  
Yuhe Qiu ◽  
Yaxi Zhang ◽  
Shilian Liu ◽  
Juan Shi ◽  
...  

APOPTOSIS ◽  
2009 ◽  
Vol 14 (10) ◽  
pp. 1190-1203 ◽  
Author(s):  
Magali Brabant ◽  
Ludwig Baux ◽  
Richard Casimir ◽  
Jean Paul Briand ◽  
Olivier Chaloin ◽  
...  

2000 ◽  
Vol 275 (24) ◽  
pp. 17974-17978 ◽  
Author(s):  
Zhi Chen ◽  
Jiazhi Sun ◽  
Anne Pradines ◽  
Gilles Favre ◽  
Jalila Adnane ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 263-263
Author(s):  
Christoph Kündig ◽  
Sylvain M. Cloutier ◽  
Steve Aellen ◽  
Loyse M. Felber ◽  
Jair R. Chagas ◽  
...  

2019 ◽  
Vol 65 (5) ◽  
pp. 760-765
Author(s):  
Margarita Tyndyk ◽  
Irina Popovich ◽  
A. Malek ◽  
R. Samsonov ◽  
N. Germanov ◽  
...  

The paper presents the results of the research on the antitumor activity of a new drug - atomic clusters of silver (ACS), the colloidal solution of nanostructured silver bisilicate Ag6Si2O7 with particles size of 1-2 nm in deionized water. In vitro studies to evaluate the effect of various ACS concentrations in human tumor cells cultures (breast cancer, colon carcinoma and prostate cancer) were conducted. The highest antitumor activity of ACS was observed in dilutions from 2.7 mg/l to 5.1 mg/l, resulting in the death of tumor cells in all studied cell cultures. In vivo experiments on transplanted Ehrlich carcinoma model in mice consuming 0.75 mg/kg ACS with drinking water revealed significant inhibition of tumor growth since the 14th day of experiment (maximally by 52% on the 28th day, p < 0.05) in comparison with control. Subcutaneous injections of 2.5 mg/kg ACS inhibited Ehrlich's tumor growth on the 7th and 10th days of the experiment (p < 0.05) as compared to control.


Blood ◽  
2016 ◽  
Vol 127 (13) ◽  
pp. 1676-1686 ◽  
Author(s):  
Zubin Zhang ◽  
Jiefei Tong ◽  
Xiaowen Tang ◽  
Jiaxiang Juan ◽  
Biyin Cao ◽  
...  

Key Points HERC4 is the first identified ubiquitin ligase that mediates c-Maf ubiquitination and degradation. HERC4 suppresses MM cell proliferation and delays MM tumor growth.


Metabolism ◽  
2001 ◽  
Vol 50 (10) ◽  
pp. 1213-1219 ◽  
Author(s):  
N. Nara-Ashizawa ◽  
T. Tsukada ◽  
K. Maruyama ◽  
Y. Akiyama ◽  
N. Kajimura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document